patent/RU-2418807-C2

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2418807-C2

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3d13a11da518a7da5686d3b87964b0a9
classificationCPCAdditional	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-08
filingDate	2006-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate	2011-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ebd5755f9f15bd293f5646ac09eb73e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_053c32d3da961e0efc472e2432309c4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e2b33067928087359aef0ded1ea4ddd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cf3fe0c97f2a724e95337e31df0f8d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee8943126686f4cc8f84d3d6d0901691 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf7a8eab47fc10b7e104b2ca2d6cf6a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0369c85d6ae4e51601fcd9b53f4b48a
publicationDate	2011-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	RU-2418807-C2
titleOfInvention	Compounds binding iap bir domains
abstract	FIELD: medicine, pharmaceutics. ^ SUBSTANCE: invention relates to compounds, which bind with BIR domains of IAP, namely with BIR2 and BIR3 domains. Compounds are represented by formula I It is known that apoptotic pathways play critical role in development of cancer, autoimmune disorders and neurodegenerative diseases. Also described is method of obtaining formula I compounds and their pharmaceutical compositions, as well as intermediate compounds for obtaining formula I compounds. ^ EFFECT: obtaining pharmaceutical compositions for changing apoptotic reactions in cells, which can contribute to treatment of proliferative disorders. ^ 45 cl, 1 dwg, 11 tbl, 23 ex
priorityDate	2005-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP50592 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP50591 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID22035

Total number of triples: 36.